CFL1 and neoplasm: Inhibiting PKCζ downstream integrin β1 phosphorylation (reducing adhesion) and LIMK/cofilin‐mediated actin polymerization (blocking cytoskeletal rearrangement) thereby blocking tumor cell migration and invasion